Ironwood Pharma (IRWD) Tops Q1 EPS by 6c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $66 million versus the consensus estimate of $53.58 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
• BMO Capital Reiterates Outperform Rating on HF Sinclair (DINO)